Ferring Statement on Minirin® / Octostim® / DDAVP® / Stimate® (desmopressin) Nasal Spray

Ferring Updated Statement on Minirin ® /Octostim ® /DDAVP ® /Stimate ® (desmopressin) Nasal Spray Saint-Prex, Switzerland – 3 march 2025 – Minirin ® (desmopressin) Nasal Spray 0.1 mg/ml room temperature stable (RTS)/ Octostim ® (desmopressin) Nasal Spray 1.5 mg/ml/ DDAVP ® (desmopressin acetate, 10 mcg/0.1 mL)/ Stimate ® (desmopressin acetate, 1.5 mg/1 mL) Nasal Spray/ Generic Desmopressin Acetate (10 mcg/0.1mL) Nasal Spray – Recall and Production Hold Statement Following the detection of out-of-specification results during testing, in 2020 Ferring initiated a precautionary voluntary global recall of all batches of the following products: Minirin ® (desmopressin) Nasal Spray 0.1 mg/ml room temperature stable (RTS) formulation Octostim ® (desmopressin) Nasal Spray 1.5 mg/ml DDAVP ® (desmopressin acetate, 10 mcg/0.1 mL) Stimate ® (desmopressin acetate, 1.5 mg/1 mL) Nasal Spray Generic Desmopressin Acetate (10 mcg/0.1mL) Nasal Spray Upon investigation, the root cause of the out-of-specification results was identified as a tightness issue with the primary packaging materials. To resolve this issue, new machinery has been commissioned and a variation application submitted to the European regulatory authorities on Nov 28th, 2024. Submission to the US regulatory authorities is planned Q2-2025. Deliveries to first markets will depend on regulatory authorities review and approval timelines. Ferring is committed to ensuring that our medicines adhere to the highest quality standards for our patients, and to working with health authorities to ensure alternatives for patients. Any patients or caregivers with concerns or questions about treatment alternatives should immediately contact their treating physician. If you have additional questions, please find contact details of regional Ferring teams below: US and Canada If you are based in the United States , please call our Medical Information line at 1-888-FERRING (1-888-337-7464) to discuss your question. You can also email [email protected] . If you are based in Canada , please contact [email protected] with your question and share your contact telephone number so that a member of the local team can contact you. Europe If you are based in Europe , please contact [email protected] with your question and share your contact telephone number so that a member of your local team can contact you. Asia-Pacific If you are based in India , please contact [email protected] and share your question and contact telephone number so that a member of the local team can contact you. If you are based in other locations in Asia-Pacific , please contact [email protected] with your question and share your contact telephone number so that a member of the local team can contact you. Latin America If you are based in Latin America , please contact [email protected] with your question and share your contact telephone number so that a member of the local team can contact you. Middle East and Africa If you are based in the Middle East or Africa , please email [email protected] with your question and share your contact telephone number so that a member of the local team can contact you. READ MORE PRESS RELEASES

The release as fetched from its publisher. ferring.com ↗